PATH Program for NICU Parent Mental Health
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to assist parents of preterm infants transitioning home from the NICU by testing a telehealth program called PATH. This program screens for depression, anxiety, and PTSD (post-traumatic stress disorder) and provides support based on the parents' risk levels. Parents at low risk receive a brief behavioral intervention, while those at medium to high risk are referred to community mental health services. The trial seeks parents who have had a preterm baby in the NICU for at least two weeks and speak English or Spanish. As an unphased trial, it offers a unique opportunity for parents to access tailored mental health support during a critical transition period.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this program is safe for NICU parents?
Research has not provided specific safety data for the PATH Program itself. However, the program emphasizes mental health support, typically involving activities like counseling or therapy, which are generally safe and well-received.
The PATH Program monitors for signs of depression, anxiety, and PTSD, offering short-term behavioral support. This type of support is usually safe and can enhance mental health. As the study is in a "Not Applicable" phase, it does not test new drugs, which often raise more safety concerns. Instead, it focuses on mental health care, providing emotional and psychological support.
Although specific safety data is lacking, mental health programs like this one aim to help, not harm, making them a low-risk option for participants.12345Why are researchers excited about this trial?
Researchers are excited about the PATH Program for NICU Parent Mental Health because it tackles the mental health challenges of parents with infants in the NICU through a unique approach. While standard care often involves general support, the PATH Program offers anticipatory guidance and brief behavioral interventions, providing targeted mental health strategies. This program also facilitates referrals to community mental health providers, ensuring parents receive comprehensive care tailored to their needs. By focusing on proactive mental health support, the PATH Program aims to enhance parents' well-being more effectively than traditional methods.
What evidence suggests that the PATH program is effective for NICU parent mental health?
Research shows that parents of babies in the NICU often face mental health issues like depression, anxiety, and PTSD. In this trial, the PATH program aims to help by offering mental health check-ups and support through online services. Participants in the intervention arm will receive anticipatory guidance, brief behavioral intervention, or referral to a community mental health provider. Studies have found that programs involving the whole family can improve parents' mental health. Early results suggest that providing parents with timely mental health support and connecting them to local services can be effective. This approach helps parents manage stress and enhances their overall well-being as they transition from the hospital to home.12367
Are You a Good Fit for This Trial?
This trial is for parents transitioning from the Neonatal Intensive Care Unit (NICU) to home, who may be at risk of depression, anxiety, or PTSD. It's designed to help those with at least a low risk of these conditions and provide further support for those with medium to high risk.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Telehealth-based mental health screening and engagement program using a stepped-care approach
Follow-up
Participants are monitored for mental health outcomes and engagement with community services
What Are the Treatments Tested in This Trial?
Interventions
- PATH
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
Oregon Health and Science University
Collaborator
National Institute of Mental Health (NIMH)
Collaborator